APA (7th ed.) Citation

L, C., T, C., J, S., Á, S., N, G., L, S., . . . MD, C. (2026). PCDHGC3 silencing promotes clear cell renal cell carcinoma metastasis via mTOR/HIF2α activation, lipid metabolism rewiring, and ferroptosis evasion. Cell death & disease, 17(1), . https://doi.org/10.1038/s41419-026-08643-y

Chicago Style (17th ed.) Citation

L, Celada, et al. "PCDHGC3 Silencing Promotes Clear Cell Renal Cell Carcinoma Metastasis via MTOR/HIF2α Activation, Lipid Metabolism Rewiring, and Ferroptosis Evasion." Cell Death & Disease 17, no. 1 (2026). https://doi.org/10.1038/s41419-026-08643-y.

MLA (9th ed.) Citation

L, Celada, et al. "PCDHGC3 Silencing Promotes Clear Cell Renal Cell Carcinoma Metastasis via MTOR/HIF2α Activation, Lipid Metabolism Rewiring, and Ferroptosis Evasion." Cell Death & Disease, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41419-026-08643-y.